Current Issues of Pharmacy and Medical Sciences

Prevalence of hepatitis A virus antibodies in Central-Eastern Poland – a comparative study (1990-2012)

Curr Issues Pharm Med Sci., Vol. 27, No. 1, Pages 17-19

Dariusz Pachnia, Dorota Polz-Gruszka, Paweł Macieląg, Małgorzata Polz-Dacewicz

Department of Virology, Medical University of Lublin, Chodźki 1 Str., 20-093 Lublin, Poland

DOI: 10.2478/cipms-2014-0005



Hepatitis A virus (HAV) is an hepatotropic human picornavirus that is associated only with acute infection of liver. This pathogen is mainly transmitted through the faecal-oral route, by person-to-person contact, and also contaminated drinking water and food. This reserach presenting the comparative seroepidemiological study (1990/1999/2012) on HAV infection was carried out in population from south-eastern Poland. Anti-HAV was tested in 613 subjects from 0 to over 60 years of age and the results were compared with those observed in 1990 and 1989/99. We also analyzed the number of vaccinations in the past decade and their role in preventing disease.


Full Text


HAV, anti-HAV, seroprevalence


  1. Bura M. et al.: Seroprevalence of hepatis A virus antibodies (anti-HAV) in adult inhabitants of Wielkopolska region, Poland – the role of Simple demographic factors. Ann. Agric. Environ. Med., 19, 738-741, 2012.
  2. Centers for Disease Control and Prevention: prevention of hepatitis A though active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR, Recomm. Rep., 48, 1-37, 1999.
  3. Chiroma M., et al.: Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination. Infect. Dis., 12, 271, 1471-2334, 2012.
  4. Faillon S. et al.: Impact of travel on the seroprevalence of hepatitis A in children. J. Clin. Virol., 56, 46-51, 2013.
  5. Jacobsen K.H., Koopman J.S.: Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol. Infect., 132, 1005-1022, 2004.
  6. Janaszek-Seydlitz W., Bucholc B., Wiatrzyk A.: Poziom przeciwciał przeciwko wirusowemu zapaleniu wątroby typu A u osób z terenu Warszawy. Przegl. Epidemiol., 61, 675-682, 2007.
  7. Klevens R.M. et al.: Seroprevalence of Hepatitis A Virus Antibodies in the US: Results from the National Health and Nutrition Examination Surgey. Public Health Reports, 126, 522-32, 2011.
  8. Knowles N.J. et al: Picornaviridae. [In:] King A.M.R., Adams MJ, Carstens EB, Lefkowitz EJ (editors) Virus taxonomy: classification and nomenclature of viruses: ninth report of the international committee on taxonomy of viruses. Elsevier, San Diego, pp 855-880, 2012
  9. Krumbholz A. et al.: Prevalence of antibodies against hepatitis A virus among children and adolescents in Germany. Med. Microbiol. Immunol., doi 10.1007/s00430-013-0303-4
  10. Kurkela S. et al.: Comparative hepatitis A seroepidemiology in 10 European countries. Epidemiol. Infect., 140, 2172-2181, 2012,doi:10.1017/S0950268812000015.
  11. Lee H.C. et al.: Changing epidemiological patterns of hepatitis A infection in Singapore. Ann. Acad. Med. Singapore, 40, 439-447, 2011.
  12. MacDonald al.: Increase in hepatitis A in tourists from Denmark, England, Germany, the Netherlands, Norway and Sweden returning from Egypt, November 2012 to March 2013. Euro Surveill., 18, pii=20468, 2013.
  13. Polz-Dacewicz M., Policzkiewicz P., Badach Z.: Changing epidemiology of hepatitis A virus infection – a comparative study in Central Eastern Poland (1990-1999). Med Sci Monit 6, 989-993, 2000.
  14. Van Herck K., Jacquet J.M., Van Damme P.: Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years. J. Med. Virol., 83, 1885-91, 2011, doi: 10.1002/jmv.22200.
  15. Whelan J. et al.: Evaluation of hepatitis a vaccine in post-exposure prophylaxis, the Netherlands, 2004-2012. PLoS One., 17;8; e:78914, 2013, doi: 10.1371/journal.pone.0078914.


April 2020

Mon Tue Wed Thu Fri Sat Sun
    01 02 03 04 05
06 07 08 09 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30